Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2020 Filed Mar 3, 2020 21:32 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
Exercise / conversionCommon Stock | 350 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-009013 · form4.xml · nonDerivative · entry 1 JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,580 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:30 UTC |
Garner Todd WExecutive Vice President & CFO
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 1,600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-009007 · form4.xml · derivative · entry 3 Garner Todd W. · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,800 Underlying: Common Stock · 1,600 shares Expires 2029-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:30 UTC |
Garner Todd WExecutive Vice President & CFO
|
Tax withholdingCommon Stock | 784 | $94.64 | $74,197.76 |
DisclosureSEC source: 0001127602-20-009007 · form4.xml · nonDerivative · entry 2 Garner Todd W. · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,305 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:30 UTC |
Garner Todd WExecutive Vice President & CFO
|
Exercise / conversionCommon Stock | 1,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-009007 · form4.xml · nonDerivative · entry 1 Garner Todd W. · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,089 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:26 UTC |
Folkert NathanVP GM Orthopedics
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 400 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-008994 · form4.xml · derivative · entry 6 Folkert Nathan · CIK 0001654392 · VP GM Orthopedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400 Underlying: Common Stock · 400 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:26 UTC |
Folkert NathanVP GM Orthopedics
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-008994 · form4.xml · derivative · entry 5 Folkert Nathan · CIK 0001654392 · VP GM Orthopedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 500 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:26 UTC |
Folkert NathanVP GM Orthopedics
|
Tax withholdingCommon Stock | 98 | $94.64 | $9,274.72 |
DisclosureSEC source: 0001127602-20-008994 · form4.xml · nonDerivative · entry 4 Folkert Nathan · CIK 0001654392 · VP GM Orthopedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,280 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:26 UTC |
Folkert NathanVP GM Orthopedics
|
Exercise / conversionCommon Stock | 400 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-008994 · form4.xml · nonDerivative · entry 3 Folkert Nathan · CIK 0001654392 · VP GM Orthopedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,378 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:26 UTC |
Folkert NathanVP GM Orthopedics
|
Tax withholdingCommon Stock | 122 | $94.64 | $11,546.08 |
DisclosureSEC source: 0001127602-20-008994 · form4.xml · nonDerivative · entry 2 Folkert Nathan · CIK 0001654392 · VP GM Orthopedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,978 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:26 UTC |
Folkert NathanVP GM Orthopedics
|
Exercise / conversionCommon Stock | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-008994 · form4.xml · nonDerivative · entry 1 Folkert Nathan · CIK 0001654392 · VP GM Orthopedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:24 UTC |
Cohen Heather LEVP CORP HR
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 300 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-008986 · form4.xml · derivative · entry 3 Cohen Heather L · CIK 0001436649 · EVP CORP HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 300 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:24 UTC |
Cohen Heather LEVP CORP HR
|
Tax withholdingCommon Stock | 102 | $94.64 | $9,653.28 |
DisclosureSEC source: 0001127602-20-008986 · form4.xml · nonDerivative · entry 2 Cohen Heather L · CIK 0001436649 · EVP CORP HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,166 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:24 UTC |
Cohen Heather LEVP CORP HR
|
Exercise / conversionCommon Stock | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-008986 · form4.xml · nonDerivative · entry 1 Cohen Heather L · CIK 0001436649 · EVP CORP HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,268 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:22 UTC |
Beyer PatPresident - International
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 725 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-008979 · form4.xml · derivative · entry 3 Beyer Pat · CIK 0001627985 · President - International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 725 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:22 UTC |
Beyer PatPresident - International
|
Tax withholdingCommon Stock | 341 | $94.64 | $32,272.24 |
DisclosureSEC source: 0001127602-20-008979 · form4.xml · nonDerivative · entry 2 Beyer Pat · CIK 0001627985 · President - International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,807 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:22 UTC |
Beyer PatPresident - International
|
Exercise / conversionCommon Stock | 725 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-008979 · form4.xml · nonDerivative · entry 1 Beyer Pat · CIK 0001627985 · President - International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,148 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:18 UTC |
Berge Terence MVP-Corporate Controller
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-008972 · form4.xml · derivative · entry 3 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 250 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:18 UTC |
Berge Terence MVP-Corporate Controller
|
Tax withholdingCommon Stock | 123 | $94.64 | $11,640.72 |
DisclosureSEC source: 0001127602-20-008972 · form4.xml · nonDerivative · entry 2 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,035 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:18 UTC |
Berge Terence MVP-Corporate Controller
|
Exercise / conversionCommon Stock | 250 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-008972 · form4.xml · nonDerivative · entry 1 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,158 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2020 Filed Feb 6, 2020 21:28 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
SaleCommon Stock | 187 | $104.18 | $19,481.29 |
DisclosureSEC source: 0001127602-20-003997 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38 Read SEC document |
| January 31, 2020 Filed Feb 4, 2020 21:14 UTC |
Hartman Curt RDirector · President & CEO
|
Exercise / conversionPSUs (Performance Stock Units) · Derivative | 104,000 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001127602-20-003499 · form4.xml · derivative · entry 4 Hartman Curt R · CIK 0001451535 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 104,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: 104,000 shares represent vesting of Performance Stock Units disclosed in the Form 8-K Current Report dated February 24, 2015 as determined by the January 31, 2020 Compensation Committee certification that CONMED total shareholder return for the five year performance period outperformed the S&P 1500 Health Care Equipment Select Index (the "Index") with performance of 106.07% relative to the Index, resulting in an award of 104,000 shares, with the Company withholding 48,903 shares for payment of withholding taxes. F1 · derivative.expiration_date: 104,000 shares represent vesting of Performance Stock Units disclosed in the Form 8-K Current Report dated February 24, 2015 as determined by the January 31, 2020 Compensation Committee certification that CONMED total shareholder return for the five year performance period outperformed the S&P 1500 Health Care Equipment Select Index (the "Index") with performance of 106.07% relative to the Index, resulting in an award of 104,000 shares, with the Company withholding 48,903 shares for payment of withholding taxes. Read SEC document |
| January 31, 2020 Filed Feb 4, 2020 21:14 UTC |
Hartman Curt RDirector · President & CEO
|
GrantPSUs (Performance Stock Units) · Derivative | 104,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-003499 · form4.xml · derivative · entry 3 Hartman Curt R · CIK 0001451535 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,000 Underlying: Common Stock · 104,000 shares Expires not disclosed F1 · derivative.expiration_date: 104,000 shares represent vesting of Performance Stock Units disclosed in the Form 8-K Current Report dated February 24, 2015 as determined by the January 31, 2020 Compensation Committee certification that CONMED total shareholder return for the five year performance period outperformed the S&P 1500 Health Care Equipment Select Index (the "Index") with performance of 106.07% relative to the Index, resulting in an award of 104,000 shares, with the Company withholding 48,903 shares for payment of withholding taxes. Read SEC document |
| January 31, 2020 Filed Feb 4, 2020 21:14 UTC |
Hartman Curt RDirector · President & CEO
|
Tax withholdingCommon Stock | 48,903 | $101.68 | $4,972,457.04 |
DisclosureSEC source: 0001127602-20-003499 · form4.xml · nonDerivative · entry 2 Hartman Curt R · CIK 0001451535 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,801 Read SEC document |
| January 31, 2020 Filed Feb 4, 2020 21:14 UTC |
Hartman Curt RDirector · President & CEO
|
Exercise / conversionCommon Stock | 104,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-003499 · form4.xml · nonDerivative · entry 1 Hartman Curt R · CIK 0001451535 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,704 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: 104,000 shares represent vesting of Performance Stock Units disclosed in the Form 8-K Current Report dated February 24, 2015 as determined by the January 31, 2020 Compensation Committee certification that CONMED total shareholder return for the five year performance period outperformed the S&P 1500 Health Care Equipment Select Index (the "Index") with performance of 106.07% relative to the Index, resulting in an award of 104,000 shares, with the Company withholding 48,903 shares for payment of withholding taxes. Read SEC document |
| January 02, 2020 Filed Jan 3, 2020 20:44 UTC |
Garner Todd WExecutive Vice President & CFO
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 2,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-000583 · form4.xml · derivative · entry 3 Garner Todd W. · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 2,000 shares Expires 2028-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.001 per share of Conmed Corporation (the "Company") and was granted outside of the Company's existing equity plan as "employment inducement grants" under NASDAQ Listing Rule 5635(c)(4) and vest in equal amounts (25%) over a four year period on the January 2 anniversary date of the award, as further described in the Current Report filed with the SEC by the Company on January 2, 2018. Read SEC document |
| January 02, 2020 Filed Jan 3, 2020 20:44 UTC |
Garner Todd WExecutive Vice President & CFO
|
Tax withholdingCommon Stock | 1,040 | $111.23 | $115,679.20 |
DisclosureSEC source: 0001127602-20-000583 · form4.xml · nonDerivative · entry 2 Garner Todd W. · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,489 Read SEC document |
| January 02, 2020 Filed Jan 3, 2020 20:44 UTC |
Garner Todd WExecutive Vice President & CFO
|
Exercise / conversionCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-000583 · form4.xml · nonDerivative · entry 1 Garner Todd W. · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,529 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 20:53 UTC |
Ruiz-Caban WilfredoEVP QA, RA and Operations
|
GrantCommon Stock | 16 | $106.24 | $1,699.84 |
DisclosureSEC source: 0001127602-20-000592 · form4.xml · nonDerivative · entry 1 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,574 Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 19:57 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
GrantCommon Stock | 44 | $106.24 | $4,674.56 |
DisclosureSEC source: 0001127602-20-000494 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225 Read SEC document |
| December 31, 2019 Filed Feb 13, 2020 21:53 UTC |
Cohen Heather LEVP CORP HR
|
Other401 (K) Plan | 48.267 | $111.83 | $5,397.70 |
DisclosureSEC source: 0001127602-20-005322 · form5.xml · nonDerivative · entry 1 Cohen Heather L · CIK 0001436649 · EVP CORP HR 10b5-1 filing: Not disclosed Ownership: Indirect · 401 (K) Plan Disclosed balance after: 4,852.412 F1 · date: As of December 31, 2019. F2 · balance_after: No change in holdings other than as a result of a change in the shares of stock in the 401 (K) Conmed fund. Read SEC document |
| December 31, 2019 Filed Feb 13, 2020 21:56 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
Other401 (K) Plan | 933.285 | $111.83 | $104,369.26 |
DisclosureSEC source: 0001127602-20-005324 · form5.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Indirect · 401 (K) Plan Disclosed balance after: 933.285 F1 · date: As of December 31, 2019. F2 · balance_after: Shares of stock in the 401 (K) Conmed fund. Read SEC document |
| December 13, 2019 Filed Dec 16, 2019 20:00 UTC |
SHAGORY PETER KEVP, STRAT & CORP DEVT
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 1,500 | $0.00 Strike: $41.93 | $0.00 |
DisclosureSEC source: 0001127602-19-035009 · form4.xml · derivative · entry 3 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 1,500 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| December 13, 2019 Filed Dec 16, 2019 20:00 UTC |
SHAGORY PETER KEVP, STRAT & CORP DEVT
|
SaleCommon Stock | 1,500 | $111.02 | $166,530.00 |
DisclosureSEC source: 0001127602-19-035009 · form4.xml · nonDerivative · entry 2 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,649 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.01 to $111.04. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| December 13, 2019 Filed Dec 16, 2019 20:00 UTC |
SHAGORY PETER KEVP, STRAT & CORP DEVT
|
Exercise / conversionCommon Stock | 1,500 | $41.93 | $62,895.00 |
DisclosureSEC source: 0001127602-19-035009 · form4.xml · nonDerivative · entry 1 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,149 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 17:32 UTC |
KENNEDY JOHN JEDVP GM CET
|
SaleCommon Stock | 5,965 | $112.42 | $670,585.30 |
DisclosureSEC source: 0001127602-19-034731 · form4.xml · nonDerivative · entry 1 KENNEDY JOHN JED · CIK 0001287981 · VP GM CET 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,497 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.37 to $112.52. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder. Read SEC document |
| December 05, 2019 Filed Dec 6, 2019 21:14 UTC |
KENNEDY JOHN JEDVP GM CET
|
Exercise / conversionSars (Stock Appreciation Rights) · Derivative | 19,520 | $0.00 Strike: $51.30 | $0.00 |
DisclosureSEC source: 0001127602-19-034458 · form4.xml · derivative · entry 3 KENNEDY JOHN JED · CIK 0001287981 · VP GM CET 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,880 Underlying: Common Stock · 19,520 shares Expires 2025-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (20%) over a five year period. Read SEC document |
| December 05, 2019 Filed Dec 6, 2019 21:14 UTC |
KENNEDY JOHN JEDVP GM CET
|
Tax withholdingCommon Stock | 13,555 | $113.91 | $1,544,050.05 |
DisclosureSEC source: 0001127602-19-034458 · form4.xml · nonDerivative · entry 2 KENNEDY JOHN JED · CIK 0001287981 · VP GM CET 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,462 Read SEC document |
| December 05, 2019 Filed Dec 6, 2019 21:14 UTC |
KENNEDY JOHN JEDVP GM CET
|
Exercise / conversionCommon Stock | 19,520 | $51.30 | $1,001,376.00 |
DisclosureSEC source: 0001127602-19-034458 · form4.xml · nonDerivative · entry 1 KENNEDY JOHN JED · CIK 0001287981 · VP GM CET 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,017 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 04, 2019 Filed Dec 5, 2019 21:32 UTC |
KENNEDY JOHN JEDVP GM CET
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 5,400 | $0.00 Strike: $59.96 | $0.00 |
DisclosureSEC source: 0001127602-19-034365 · form4.xml · derivative · entry 10 KENNEDY JOHN JED · CIK 0001287981 · VP GM CET 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,600 Underlying: Common Stock · 5,400 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| December 04, 2019 Filed Dec 5, 2019 21:32 UTC |
KENNEDY JOHN JEDVP GM CET
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $41.93 | $0.00 |
DisclosureSEC source: 0001127602-19-034365 · form4.xml · derivative · entry 9 KENNEDY JOHN JED · CIK 0001287981 · VP GM CET 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 10,000 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| December 04, 2019 Filed Dec 5, 2019 21:32 UTC |
KENNEDY JOHN JEDVP GM CET
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 14,820 | $0.00 Strike: $39.87 | $0.00 |
DisclosureSEC source: 0001127602-19-034365 · form4.xml · derivative · entry 8 KENNEDY JOHN JED · CIK 0001287981 · VP GM CET 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,880 Underlying: Common Stock · 14,820 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| December 04, 2019 Filed Dec 5, 2019 21:32 UTC |
KENNEDY JOHN JEDVP GM CET
|
SaleCommon Stock | 11,354 | $115.03 | $1,306,050.62 |
DisclosureSEC source: 0001127602-19-034365 · form4.xml · nonDerivative · entry 7 KENNEDY JOHN JED · CIK 0001287981 · VP GM CET 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,497 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.66 to $115.41. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| December 04, 2019 Filed Dec 5, 2019 21:32 UTC |
KENNEDY JOHN JEDVP GM CET
|
Tax withholdingCommon Stock | 3,965 | $114.92 | $455,657.80 |
DisclosureSEC source: 0001127602-19-034365 · form4.xml · nonDerivative · entry 6 KENNEDY JOHN JED · CIK 0001287981 · VP GM CET 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,851 Read SEC document |
| December 04, 2019 Filed Dec 5, 2019 21:32 UTC |
KENNEDY JOHN JEDVP GM CET
|
Exercise / conversionCommon Stock | 5,400 | $59.96 | $323,784.00 |
DisclosureSEC source: 0001127602-19-034365 · form4.xml · nonDerivative · entry 5 KENNEDY JOHN JED · CIK 0001287981 · VP GM CET 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,816 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 04, 2019 Filed Dec 5, 2019 21:32 UTC |
KENNEDY JOHN JEDVP GM CET
|
Tax withholdingCommon Stock | 6,469 | $114.92 | $743,417.48 |
DisclosureSEC source: 0001127602-19-034365 · form4.xml · nonDerivative · entry 4 KENNEDY JOHN JED · CIK 0001287981 · VP GM CET 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,416 Read SEC document |
| December 04, 2019 Filed Dec 5, 2019 21:32 UTC |
KENNEDY JOHN JEDVP GM CET
|
Exercise / conversionCommon Stock | 10,000 | $41.93 | $419,300.00 |
DisclosureSEC source: 0001127602-19-034365 · form4.xml · nonDerivative · entry 3 KENNEDY JOHN JED · CIK 0001287981 · VP GM CET 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,885 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 04, 2019 Filed Dec 5, 2019 21:32 UTC |
KENNEDY JOHN JEDVP GM CET
|
Tax withholdingCommon Stock | 8,432 | $114.81 | $968,077.92 |
DisclosureSEC source: 0001127602-19-034365 · form4.xml · nonDerivative · entry 2 KENNEDY JOHN JED · CIK 0001287981 · VP GM CET 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,885 Read SEC document |
| December 04, 2019 Filed Dec 5, 2019 21:32 UTC |
KENNEDY JOHN JEDVP GM CET
|
Exercise / conversionCommon Stock | 14,820 | $39.87 | $590,873.40 |
DisclosureSEC source: 0001127602-19-034365 · form4.xml · nonDerivative · entry 1 KENNEDY JOHN JED · CIK 0001287981 · VP GM CET 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,317 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2019 Filed Dec 3, 2019 22:17 UTC |
Council LaVerne HDirector
|
GrantOptions To Purchase Common Stock · Derivative | 987 | $0.00 Strike: $112.55 | $0.00 |
DisclosureSEC source: 0001127602-19-034171 · form4.xml · derivative · entry 2 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 987 Underlying: Common Stock · 987 shares Expires 2029-12-02 F2 · derivative.exercise_date: The incentive stock options ("Options") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan with the Options generally vesting on December 2, 2020 subject to the director's completion of the term of service through the next annual shareholder meeting Read SEC document |
| December 02, 2019 Filed Dec 3, 2019 22:17 UTC |
Council LaVerne HDirector
|
GrantRsus (restricted Stock Units) · Derivative | 599 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-034171 · form4.xml · derivative · entry 1 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 599 Underlying: Common Stock · 599 shares Expires 2029-12-02 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting on December 2, 2020 subject to the director's completion of the term of service through the next annual shareholder meeting. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.